FY2024 EPS Estimates for ICON Public Lifted by William Blair

ICON Public Limited (NASDAQ:ICLR) – William Blair increased their FY2024 earnings estimates for ICON Public in a report issued on Wednesday, January 15th. William Blair analyst M. Smock now forecasts that the medical research company will post earnings of $13.55 per share for the year, up from their previous estimate of $13.40. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for ICON Public’s current full-year earnings is $13.41 per share. William Blair also issued estimates for ICON Public’s FY2025 earnings at $13.33 EPS.

Several other research analysts have also commented on the company. Evercore ISI dropped their price target on ICON Public from $360.00 to $350.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Citigroup lowered their price target on ICON Public from $300.00 to $290.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Redburn Atlantic began coverage on shares of ICON Public in a research report on Monday, October 14th. They set a “neutral” rating and a $311.00 price objective on the stock. TD Cowen lowered their target price on shares of ICON Public from $369.00 to $285.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $263.00 price target on shares of ICON Public in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $287.00.

ICON Public Price Performance

ICON Public stock opened at $198.11 on Monday. ICON Public has a 52-week low of $183.38 and a 52-week high of $347.72. The company has a market cap of $16.34 billion, a price-to-earnings ratio of 22.09, a PEG ratio of 1.59 and a beta of 1.20. The firm’s fifty day moving average is $209.43 and its 200 day moving average is $266.68. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 0.35.

ICON Public (NASDAQ:ICLR) last issued its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.72 by ($0.37). ICON Public had a return on equity of 11.91% and a net margin of 9.00%. The firm had revenue of $2.03 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same period last year, the firm posted $3.10 earnings per share. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year.

Hedge Funds Weigh In On ICON Public

Large investors have recently made changes to their positions in the business. Park Place Capital Corp increased its position in ICON Public by 281.4% during the 4th quarter. Park Place Capital Corp now owns 225 shares of the medical research company’s stock valued at $47,000 after buying an additional 166 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of ICON Public by 39.2% during the second quarter. EverSource Wealth Advisors LLC now owns 394 shares of the medical research company’s stock valued at $129,000 after acquiring an additional 111 shares in the last quarter. GAMMA Investing LLC raised its position in shares of ICON Public by 64.0% in the 4th quarter. GAMMA Investing LLC now owns 433 shares of the medical research company’s stock valued at $91,000 after purchasing an additional 169 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in ICON Public by 23.1% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 511 shares of the medical research company’s stock worth $147,000 after purchasing an additional 96 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its position in ICON Public by 33.9% during the 3rd quarter. First Horizon Advisors Inc. now owns 597 shares of the medical research company’s stock worth $172,000 after purchasing an additional 151 shares during the last quarter. 95.61% of the stock is owned by institutional investors and hedge funds.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.